Page last updated: 2024-09-05

n(4)-hydroxycytidine and Hemorrhagic Fever, Ebola

n(4)-hydroxycytidine has been researched along with Hemorrhagic Fever, Ebola in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bluemling, GR; Brasel, T; Comer, JE; De La Rosa, A; Freiberg, AN; Kolykhalov, AA; Lockwood, M; Mao, S; Mulangu, S; Natchus, MG; Painter, GR; Painter, W1

Other Studies

1 other study(ies) available for n(4)-hydroxycytidine and Hemorrhagic Fever, Ebola

ArticleYear
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N
    Antiviral research, 2023, Volume: 209

    Topics: Animals; Antiviral Agents; Ebolavirus; Hemorrhagic Fever, Ebola; Mice; Ribonucleosides

2023